Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CHMP issues negative opinion on Glybera MAA

June 28, 2011

EMA continues review of pioglitazone-based medicines

June 28, 2011

Blocking Smad1 phosphorylation may reduce diabetic nephropathy

June 28, 2011

CHMP recommends approval of linagliptin for type 2 diabetes

June 27, 2011

Once-weekly exenatide approved in E.U. for type 2 diabetes

June 22, 2011

Cebix advances C peptide replacement therapy for chronic complications of diabetes

June 22, 2011

EMA committee accepts for review PROLOR's PIP for long-acting human growth hormone

June 22, 2011

MK-0916 reduces HbA1c and body weight in phase II trial in diabetes/metabolic syndrome

June 22, 2011

Merck & Co. patents new GPR119 receptor agonists

June 22, 2011

Plerixafor is beneficial in patients with myelokathexis

June 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...